Precision Medicine Through
Oncology Operating System™

Perthera AI offers a proprietary Personalized Cancer Therapy service that helps oncologists
identify the best treatment options for patients to fight cancer.

Precision Medicine Through
Oncology Operating System™

Perthera AI offers a proprietary Personalized Cancer Therapy service that helps oncologists
identify the best treatment options for patients to fight cancer.

Visit us at ASCO at booth 27102 on 4 Jun – 6 Jun 2022

Visit us at ASCO at booth 27102 on 4 Jun – 6 Jun 2022

Perthera is leading by delivering

Precision Medicine Through Oncology Operating System™

Perthera AI is an oncology company that has pioneered the use of genomics to advise doctors & patients on optimal treatment options through the Oncology Operating System™. Perthera uses AI to identify the best drugs available for that individual, giving patients a ‘performance prediction score’ for every available therapeutic.

The Perthera method and Oncology OS™ have been published and clinical proven to increase survival rates for thousands of patients and are the best resource available today for oncologists in their treatment decision-making process. Perthera’s clients & partners include Mayo Clinic, Pfizer, AstraZeneca, Novartis, the Department of Defense, and many others.

WHY PERTHERA​

Our patient story

Lee S., a breast cancer survivor and Oncology Data Specialist, shares why the Perthera Report is so important for cancer patients.

Services

For Over A Decade In Precision Medicine Area​

Patients

Physicians

Advocacy

CROs & Labs

Pharma & Drug Development

Payers

The Perthera Analysis

The Perthera Analysis is the only clinically proven precision oncology analysis which recommends clinical trials and treatment options specific to each patient’s cancer.

Perthera For Physicians

The Perthera Analysis recommends clinical trials and treatments specific to each patient’s cancer to give physicians the supportive information needed to treat their patients.

Perthera For Physicians

The Perthera Analysis recommends clinical trials and treatments specific to each patient’s cancer to give physicians the supportive information needed to treat their patients.

Perthera For Patients

Every cancer is unique, and Perthera is committed to providing the best treatment options specific to each patient for a greater likelihood of an improved outcome.

Perthera For Clinical Partners​

Perthera helps its partners, CROs, Labs Advocacy & Payers to achieve various goals like RWE, track & capture outcomes; curate, structure data for abstracts used for research purposes, clinical trial enrollments, potentially reducing treatment costs.

Perthera For Clinical Partners​

Perthera helps its partners, CROs, Labs Advocacy & Payers to achieve various goals like RWE, track & capture outcomes; curate, structure data for abstracts used for research purposes, clinical trial enrollments, potentially reducing treatment costs.

meet the team

Perthera Leadership Team​

The Leadership team at Perthera is dedicated to serving our clients and their patients with the best in clinical decision support. We work hard to deliver the best in healthcare innovation and multi-omic insights.

Albert Kelley
president & CEO Board Member
Chip Petricoin
Chief Science Officer
Yuri Frayman
Chief Product Officer
Michael Pishvaian
Chief Medical Officer
TESTIMONIALS

This is why we do what we do